What is the share price of Farmax India Ltd (FARMAXIND)?

Company share prices are keep on changing according to the market conditions. The current trading price of Farmax India Ltd (FARMAXIND) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Farmax India?

The latest standalone P/E ratio of Farmax India as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Farmax India Ltd (FARMAXIND)?

The latest standalone P/B ratio of Farmax India Ltd (FARMAXIND) as of 01-Jan-1970 is -0.26.

What is the 52-week high and low of Farmax India Ltd (FARMAXIND)?

The 52-week high of Farmax India Ltd (FARMAXIND) is Rs. 0.09 and the 52-week low is Rs. 0.09.

Farmax India Ltd (FARMAXIND) Share Analysis – Brand Strength, Quality & Valuation Zone & DeciZen Rating

Name: Farmax India Ltd (FARMAXIND)
Brand: Farmax India

Farmax India Ltd (FARMAXIND)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590094 NSE: FARMAXIND Consumer Food | Small Cap | Farmax India Share Price

Farmax India Ltd (FARMAXIND)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590094 NSE: FARMAXIND Consumer Food | Small Cap | Farmax India Share Price

Key Metrics

Valuation Multiples

Market Cap

₹5 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹-0.1

TTM Sales

₹4.4 Cr.

Book Value per Share

₹-0.4

P/E Ratio

0.00

Industry PE

55.5

Price to Book (P/B)

-0.26

Price to Sales (P/S)

1.10

EV/EBITDA

-31.73

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

0.00%

Return on Capital Employed (ROCE)

-11.69%

Return on Assets (ROA)

-8.56%

Operating Profit Margin

-33.9%

Net Profit Margin

-63.01%

Gross Profit Margin

-33%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-73.31%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

30.98%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹-72 Cr.

Equity

₹53.4 Cr.

Face Value

₹1

All Time Low / High

₹0.09 / 46.00

Farmax India stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
ROCE % ⓘ	0%	8.4%	16.3%	3.1%	1%	-165.8%	-12.1%	-7.4%	-32.7%	-11.7%	-
Growth Parameters ⓘ
Sales ⓘ	0	19.9	64.5	77.3	91.4	51.9	17.4	21	16.4	4.4	4
Sales YoY Gr.	-	NA	224.2%	19.7%	18.3%	-43.2%	-66.5%	20.8%	-22%	-73.3%	-
Adj EPS ⓘ	0	0	0.3	0.1	-0.1	-1.4	-0.2	-0	-0.2	-0.1	-0.1
YoY Gr.	-	NA	550%	-69.2%	-187.5%	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	0	1.6	1.9	13	3.6	-0.3	-0.5	-0.1	-0.3	-0.4	-0.4
Adj Net Profit ⓘ	0	0.4	3.2	2.1	-1.8	-55.6	-8.8	-2.1	-9.8	-2.8	-3
Cash Flow from Ops. ⓘ	0	1.5	-5	-4.5	-2.9	-20	-0.5	-17.4	-0.4	0	-
Debt/CF from Ops. ⓘ	0	7.5	-3.2	-5.8	-10.6	-1.8	-88.5	-2.4	-99.3	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-45.5%	-36.9%	-73.3%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	-162.7%	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
Return on Equity % ⓘ	3	11.5	1.2	-0.8	-115.8	95.3	33.1	239.8	26.7	14.3
Op. Profit Mgn % ⓘ	10.4	13.1	9.6	5.9	-32.9	-6.3	-7.9	-51.6	-33.9	-26
Net Profit Mgn % ⓘ	2.1	5	2.8	-2	-107.1	-50.8	-10.1	-59.6	-63	-61
Debt to Equity ⓘ	0.6	0.7	0.1	0.3	-2.9	-2	-6.5	-2.6	-2.2	-
Working Cap Days ⓘ	108	92	292	417	403	179	288	441	1,203	211
Cash Conv. Cycle ⓘ	54	55	91	112	119	51	144	229	535	-635

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'07	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Sales	0	19.90	64.52	77.25	91.42	51.92	17.41	21.03	16.41	4.38
Operating Expenses ⓘ +	0	17.84	57.22	69.82	86.04	69.02	18.51	22.69	24.87	5.87
Manufacturing Costs	0	1.66	7.01	2.20	1.65	1.27	1	0.88	0.82	0.23
Material Costs	0	15.28	45.21	58.89	78.84	59.98	15.90	20.14	21.84	4.92
Employee Cost	0	0.22	1.21	3.07	2.86	1.36	1.03	1.21	1.19	0.44
Other Costs ⓘ	0	0.68	3.79	5.67	2.68	6.42	0.58	0.46	1.03	0.28
Operating Profit ⓘ	0	2.06	7.30	7.43	5.39	-17.10	-1.10	-1.66	-8.46	-1.49
Operating Profit Margin (%)	-	10.3%	11.3%	9.6%	5.9%	-32.9%	-6.3%	-7.9%	-51.6%	-33.9%
Other Income ⓘ +	0	0	0.02	1.26	1.75	0.37	0.38	1.78	0.29	0.04
Exceptional Items ⓘ	0	0	0	0	0	-102.59	0	0	0	0
Interest ⓘ	0	0.60	2.43	3.73	4.82	4.73	6.18	0.06	0.01	0
Depreciation ⓘ	0	0.78	1.67	2.45	4.76	2.54	1.94	2.17	1.60	1.32
Profit Before Tax ⓘ	0	0.68	3.22	2.51	-2.44	-126.59	-8.84	-2.10	-9.78	-2.76
Tax ⓘ	0	0.25	0.78	0.36	-0.60	0.72	0	0	0	0
Profit After Tax	0	0.42	2.44	2.14	-1.84	-127.32	-8.84	-2.10	-9.78	-2.76
PAT Margin (%)	-	2.1%	3.8%	2.8%	-2.0%	-245.0%	-50.8%	-10.0%	-59.6%	-63.0%
Adjusted EPS (₹)	0.0	0.0	0.2	0.1	-0.1	-3.1	-0.2	-0.0	-0.2	-0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Farmax India - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'07	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Equity and Liabilities
Shareholders Fund +	3.22	25	31.44	342	100.86	-4.86	-13.70	0.81	-8.97	-11.73
Share Capital ⓘ	3.22	11	12.60	25.83	25.83	40.83	40.83	53.42	53.42	53.42
Reserves ⓘ	0	14	18.84	316.17	75.03	-45.69	-54.53	-52.61	-62.39	-65.15
Debt +	0.02	11.18	16.13	24.25	23.12	29.67	41.49	41.02	41	41
Long Term Debt	0.02	11.18	16.13	6.98	0.49	0.43	0.42	0.45	0.73	0.73
Short Term Debt	0	0	0	17.27	22.63	29.24	41.07	40.57	40.26	40.26
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	1.92	0.71	1.72	0.85	0.36	1.58	2.49	1.38	1.01
Others Liabilities ⓘ	0.02	0.48	1.43	19.10	8.55	7.32	1.58	0.42	0.45	0.39
Total Liabilities ⓘ	3.26	38.58	49.71	387.06	133.38	32.49	30.95	44.75	33.86	30.67
Fixed Assets
Net Fixed Assets ⓘ +	0.01	23.16	28.34	30.90	26.29	23.98	22.05	20.07	18.37	17.05
Gross Block	0.03	27.02	33.87	38.87	36.95	37.09	37.10	37.29	36.38	36.38
Accumulated Depreciation	0.02	3.86	5.53	7.98	10.65	13.11	15.05	17.22	18.01	19.32
CWIP ⓘ	0	2.43	0	0	0	0	0	0	0	0
Investments ⓘ	1.11	1.15	0	253.34	0.34	0	0	0	0	0
Inventories	0	3.29	4.45	11.27	15.04	2.83	3.36	8.85	1.94	0.18
Trade Receivables	0	4.50	10.09	15.50	16.93	0.16	0.17	6.93	6.19	6.25
Cash Equivalents	0	0.21	0.16	0.04	0.03	0.09	0.01	0.24	0.20	0.02
Others Assets ⓘ	2.14	3.85	6.67	76.02	74.74	5.43	5.35	8.66	7.15	7.17
Total Assets ⓘ	3.26	38.58	49.71	387.06	133.38	32.49	30.95	44.75	33.86	30.67

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'07	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Cash Flow From Operating Activity ⓘ +	-0.01	1.49	-5.02	-4.54	-2.85	-19.95	-0.47	-17.43	-0.41
PBT ⓘ	-0.01	0.68	3.22	2.51	-2.44	-126.59	-8.84	-2.10	-9.78
Adjustment ⓘ	0	1.11	2.41	2.56	4.27	109.04	7.70	0.44	1.32
Changes in Working Capital ⓘ	0	-0.07	-9.76	-9.31	-4.68	-2.4	0.67	-15.77	8.05
Tax Paid ⓘ	0	-0.23	-0.89	-0.29	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	0	-3.30	-4.51	-325.82	1.27	-3.78	0.42	1.56	1.22
Capex	0	-3.17	-4.41	-5.01	-0.07	-0.15	-0.01	-0.19	0.93
Net Investments	0	0	0	-322.07	-0.42	-4.01	0.05	-0.04	0
Others ⓘ	0	-0.13	-0.10	1.26	1.75	0.37	0.38	1.78	0.29
Cash Flow From Financing Activity ⓘ +	0.01	1.29	4.63	330.24	1.58	23.79	-0.03	16.09	-4.06
Net Proceeds from Shares ⓘ	0	0	0	308.41	0	21.60	0	16.62	-4.03
Net Proceeds from Borrowing ⓘ	0	0	0	12.95	-1.75	0	0	0	0
Interest Paid ⓘ	0	-0.33	-0.74	-1.37	-1.35	-4.36	-6.14	-0.06	-0.01
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0.01	1.62	5.37	10.24	4.67	6.55	6.11	-0.46	-0.03
Net Cash Flow ⓘ	-0	-0.52	-4.90	-0.12	-0	0.06	-0.08	0.22	-3.25

Financial Ratio

PARTICULARS	Mar'07	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Ratios
ROE (%)	0	4.42	11.59	1.19	-0.86	N/A	N/A	0	N/A	N/A
ROCE (%)	0	8.4	16.27	3.11	0.98	N/A	N/A	-7.37	N/A	N/A
Asset Turnover Ratio	0	0.95	1.46	0.35	0.35	0.63	0.55	0.56	0.42	0.14
PAT to CFO Conversion(x)	N/A	3.55	-2.06	-2.12	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	82.60	41.30	60.50	64.80	60.10	3.50	61.60	146	518.30
Inventory Days	0	60.30	21.90	37.10	52.50	62.80	64.90	105.80	120	88.20
Payable Days	0	22.90	10.60	7.60	6	3.70	22.30	36.90	32.30	88.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Farmax India Ltd FAQs

The current trading price of Farmax India on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Farmax India stood at ₹4.81 Cr

The latest P/E ratio of Farmax India as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Farmax India as of 31-Dec-1969 is -0.26.

The 52-week high of Farmax India is ₹0.09 and the 52-week low is ₹0.09.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Farmax India is ₹4.38 ( Cr.) .

Data is not available for this company.

No data found

About Farmax India Ltd

Farmax India was promoted by M. Srinivas Reddy, in May 2003 with a single product and started out as a small partnership firm. The cmpany began its journey as Farmax Health and Food Product Pvt Ltd which was renamed as Farmax Retail India Ltd in 2005 and further renamed as Farmax India Ltd in 2009. It is a public limited company incorporated under the Companies Act, 1956, listed in the major stock exchanges in India. It is engaged in manufacturing and marketing of fast moving consumer goods (FMCG).

The company is engaged in the business of manufacturing and marketing of fast moving consumer goods. It has a manufacturing facility with advanced technology imported (machinery is one of the highly sophisticated in that category and was imported from Italian food Major) and indigenous automated machines to meet quality consistency and market demand with minimum manufacturing cost resulting affordable finished product cost with consisted quality.

Farmax India Limited has its distribution network with more than 600 distributors and approximate 4, 00,000 retail outlets situated in rural and semi urban areas.

It is having its registered office at Farmax House, 4th floor, Alluri Trade Centre, Kukatpally, Hyderabad - 500072, while its manufacturing facility is located in the vicinity of Hyderabad city at Bowrampet Village, Qutubullapur Mandal, Ranga Reddy District, in an area of 3 acres.

Products of the comapny :

Food Products

Today 365 day's
Dâ€™ Lite Pasta
Deevena Chakki Atta
Farmax Daily

Personal Care

Today Active Mint
Today FX Rel Gel
Today Pure
Mansoon

Soaps And Detargents

Cas beauty soaps
DU Detergent powder
DU Detergent cake

Awards/achievements:

Farmax India's manufacturing facility has continuous quality control and assurance operations with team of experts consisting of raw materials and packing materials analysis. In process quality control, finished goods analysis has been awarded with ISO 9001: 2008 certificate.

Farmax India Ltd (FARMAXIND)

Farmax India Ltd (FARMAXIND)

Farmax India stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Farmax India - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Farmax India Ltd FAQs

About Farmax India Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Farmax India Ltd (FARMAXIND)

Farmax India Ltd (FARMAXIND)

Farmax India stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Farmax India - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Farmax India Ltd FAQs

What is the share price of Farmax India?

What is the market cap of Farmax India?

What is the P/E ratio of Farmax India?

What is the P/B ratio of Farmax India?

What is the 52-week high and low of Farmax India?

What is the TTM revenue of Farmax India?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Farmax India Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.